Standard BioTools Inc. Q2 Loss Declines
(RTTNews) - Standard BioTools Inc. (LAB) reported Loss for second quarter of -$26.758 million
The company's earnings came in at -$26.758 million, or -$0.07 per share. This compares with -$33.459 million, or -$0.09 per share, last year.
The company's revenue for the period fell 7.6% to $20.104 million from $21.762 million last year.
Standard BioTools Inc. earnings at a glance (GAAP) :
-Earnings: -$26.758 Mln. vs. -$33.459 Mln. last year. -EPS: -$0.07 vs. -$0.09 last year. -Revenue: $20.104 Mln vs. $21.762 Mln last year.
Standard BioTools is withdrawing its full year 2026 revenue outlook given the pending merger with Treeline Biosciences.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.